The 42-Year-Old We Nearly Gave Up On!

What the New 2026 Stroke Neuro-prognostication Guidelines Mean for Acute Care Physicians

It was 3 a.m.

The emergency department had no beds left. Three ambulances were waiting outside. The ICU was full. A 42-year-old man with a large left MCA infarct had been thrombolysed and undergone thrombectomy two hours earlier.

He remained aphasic. Dense right hemiplegia. NIHSS 22. The family looked at us and asked the question we hear far too often—and far too early:

“Doctor, will he ever recover?”

In many overcrowded emergency departments, that question quietly transforms into another:

“Should we continue aggressive care?”

The uncomfortable truth is that we often neuro-prognosticate acute ischemic stroke far earlier than the science allows.

The newly published 2026 Neuro-critical Care Society Guidelines for Neuro-prognostication in Critically Ill Adults with Acute Ischemic Stroke challenge many of our traditional assumptions—and force us to reconsider how, and more importantly when, we counsel families (Mainali et al., 2026).

Why Should Acute Care Physicians Care About This?

It is tempting to think that these recommendations belong exclusively to stroke units, neuro-ICUs, or comprehensive stroke centres. After all, many patients are no longer in the emergency department 8, 12, or 72 hours after symptom onset.

But acute care medicine rarely follows ideal timelines.

Patients arrive directly from home after delayed recognition of symptoms. Others are transferred from smaller referral centres after thrombolysis, failed thrombectomy attempts, or progressive neurological deterioration. Some return days later with aspiration, cerebral edema, seizures, or worsening neurological deficits. For many of us, the first meaningful conversation about prognosis therefore happens not at 60 minutes, but at 12 hours, 24 hours, or even 72 hours after the index event, when no department is willing to take up the patient for admission.

That is precisely why these guidelines matter to every acute care physician, for such cases.

The admission NIHSS, infarct size, age, or hemorrhagic transformation do not suddenly become reliable predictors simply because more time has elapsed. The principles remain unchanged: consider the complete clinical picture, eliminate confounders, obtain appropriate imaging, and allow neurological evolution to declare itself before making definitive judgments (Mainali et al., 2026).

Whether a patient reaches your doors directly from home or after traversing multiple layers of the healthcare system, the responsibility is the same:

We must not allow geography, referral pathways, or overcrowding to shorten the timeline that the injured brain requires for recovery.

And while many patients leave our emergency departments within hours, others arrive at our doors 12, 24, or 72 hours later—from home, from smaller hospitals, or after deterioration—forcing us to answer the same difficult question: "What happens next?"

The Guideline’s Most Important Message:

Avoid Premature Neuro-prognostication

The guideline makes an unequivocal recommendation:

Avoid premature neuro-prognostication in critically ill patients with acute ischemic stroke, including severe stroke. The appropriate observation period should consider anticipated neurological evolution, confounders, and completion of diagnostic imaging (Mainali et al., 2026).

This is not a weak suggestion. It is a strong good-practice recommendation. The rationale is simple but profound. Most deaths after severe ischemic stroke occur following decisions to withhold or withdraw life-sustaining treatment, and these decisions are heavily influenced by clinician prognostication (Mainali et al., 2026).

An inaccurate early prediction can therefore become a self-fulfilling prophecy. The patient who might have walked out of the hospital six months later never gets the opportunity.

The Danger of the Self-Fulfilling Prophecy

The guideline repeatedly warns about the self-fulfilling prophecy in stroke care: when early pessimistic predictions lead to treatment limitations, and those limitations themselves determine the final outcome (Mainali et al., 2026). Most early deaths after severe ischemic stroke occur following decisions to withhold or withdraw life-sustaining treatment rather than from the primary neurological injury alone.

The message is uncomfortable but important:

The greatest risk in neuro-prognostication is not uncertainty. It is false certainty.

What We Commonly Use in the ED—And Why the Guidelines Say “Not Alone”

Perhaps the most surprising aspect of the document is how many traditional predictors failed to meet criteria for reliable neuro-prognostication.

The following should not be used alone to predict poor long-term outcome:

• Age

• Admission NIHSS

• Hyperglycemia

• Infarct size

• Hemorrhagic transformation

• Previous stroke history

• Cerebral collateral status

• Established prediction scores including ASTRAL, DRAGON, iScore, and THRIVE (Mainali et al., 2026)

In other words:

The things we often quote to families in the first few hours after presentation are precisely the things the guideline warns us against using in isolation.

Things We Should Stop Saying in the First 24 Hours

❌ “The NIHSS is 22. Recovery is unlikely.”

❌ “The infarct is too large.”

❌ “He’s too old to do well.”

❌ “There was hemorrhagic transformation, so the outcome will be poor.”

❌ “The DRAGON score predicts a bad outcome.”

What We Should Say Instead

✅ “We need to watch the neurological trajectory over the next few days before making confident predictions.”

✅ “The complete clinical picture, repeat imaging, and response to treatment matter more than any single variable.”

Even Large Infarcts Deserve Time

Large core infarcts frequently trigger therapeutic nihilism. Yet contemporary thrombectomy trials tell a more nuanced story. The guideline notes that among patients with large infarct cores receiving endovascular therapy, approximately 41% regained independent ambulation and 23% achieved functional independence—despite imaging appearances that many clinicians would traditionally associate with futility (Mainali et al., 2026).

The message is clear:

A large infarct is not synonymous with a predetermined poor outcome.

The guideline specifically notes that modern thrombectomy trials have challenged decades of therapeutic nihilism. Even among patients with large core infarcts, recovery to independent ambulation—and occasionally functional independence—is possible. Clinical trial outcomes should therefore be viewed as best-case estimates, but they remind us that imaging alone cannot determine destiny (Mainali et al., 2026).

The One Predictor That Actually Matters Early

Among all individual predictors reviewed, only one emerged as a moderately reliable predictor of good functional outcome:

Early Neurological Improvement (ENI)

Defined as:

• An improvement of ≥8 NIHSS points within 24 hours, or

• Recovery to an NIHSS of 0–1 at 24 hours (Mainali et al., 2026).

Patients demonstrating ENI had a 61–84% likelihood of returning to functional independence at three months (Mainali et al., 2026). Importantly, the absence of ENI should not be interpreted as futility.

The guideline explicitly states that delayed neurological recovery remains common, and more than one in five patients without early improvement after successful thrombectomy still achieved functional independence at three months (Mainali et al., 2026).

But Absence of Improvement Is Not Failure

The guideline is equally clear about what doesn’t matter:

Failure to improve in the first 24 hours does not preclude meaningful recovery.

More than one in five patients who did not demonstrate early neurological improvement after successful thrombectomy still achieved functional independence by three months (Mainali et al., 2026).

For acute care clinicians, that distinction matters enormously. The absence of hope is not evidence of hopelessness.

Recovery Is a Timeline, Not a Moment

Emergency physicians work in minutes. Neurological recovery unfolds across months.

The guideline recommends counseling families that patients with severe ischemic stroke may continue to experience meaningful functional gains for up to six months—and sometimes even longer (Mainali et al., 2026).

That reality changes the way we frame uncertainty. The person lying in front of us on Day 1 is not the person they may become on Month 6. And perhaps our greatest responsibility is to ensure they have the opportunity to reach that point.

The Conversation We Should Be Having Instead

Rather than saying:

“The stroke is massive. Recovery is unlikely.”

Perhaps we should say:

“It is still too early to know. The next 24–72 hours, repeat imaging, and neurological evolution will provide a clearer picture. Many patients continue improving for weeks and months.”

The guideline repeatedly emphasizes:

• Prognostication should consider the complete clinical picture.

• Confounders must be excluded before neurological assessment.

• Pre-stroke functional status matters.

• Discussions should focus on long-term outcomes rather than day-to-day fluctuations.

• Recovery after severe ischemic stroke can continue for six months or longer (Mainali et al., 2026).

These are not merely academic recommendations.

They are safeguards against therapeutic nihilism.

What Early Signs Actually Encourage Recovery?

The guideline highlights several domain-specific markers that should give clinicians cautious optimism:

🖐️ Finger extension and shoulder abduction within 48 hours often predict meaningful hand function at six months.

🚶 The ability to maintain sitting balance and demonstrate any leg contraction within 72 hours strongly predicts later ambulation.

🗣️ Aphasia recovery continues for weeks and months, sometimes beyond six months.

👁️ Visual neglect and field deficits frequently improve long after hospital discharge.

Neurological recovery is rarely binary.

It is incremental, uneven, and often far slower than our emergency department timelines allow.

What I Am Taking Back to the ED

Five Rules from the 2026 Guidelines

1. Never prognosticate from admission NIHSS alone.

2. Large infarcts deserve time.

3. Avoid discussions of futility before neurological evolution declares itself.

4. Early improvement is encouraging—but its absence is not failure.

5. Recovery after severe stroke is measured in months, not days.

Back to Our Patient

The man from the 3 a.m. shift remained hemiplegic on day one. By day three, he could lift his leg. By week two, he spoke single words. Three months later, he walked into clinic with a stick. Not independent. Not perfect.

But unquestionably a life worth living. And a reminder that overcrowding, bed shortages, and system pressures must never compress the timeline of human neurological recovery.

The 2026 guidelines ask us to replace prognostic certainty with intellectual humility.

In severe acute ischemic stroke, early findings should inform observation—not determine destiny. The most accurate prognosis is often the one delivered after allowing the brain sufficient time to declare its trajectory.

Reference

Mainali S, Fontaine GV, Rajajee V, et al. Guidelines for Neuroprognostication in Critically Ill Adults with Acute Ischemic Stroke. Neurocritical Care. 2026;44:745–769.